ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how our rules link it today.

3 links0 made here, not in the record5 judgments1 judge (our rules as one)0 record changes seen
Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03331289Can Exenatide PreventIncrease in EGP in Responseto Dapagliflozin-inducedIncrease in GlucosuriaThe University of Texas HealthPhase 4 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSDiabetes Mellitus, Type 2The registry's MeSH filing›As of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSExenatideIntervention entry›As of now · Our role rule · TestedAs of now · Our role rule · TestedTestedDapagliflozinIntervention entry›As of now · Our role rule · TestedAs of now · Our role rule · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Diabetes Mellitus, Type 2

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryDiabetes Mellitus, Type 2, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
As of nowDiabetes Mellitus, Type 2Our main-condition rule (R9)Main conditionCurrent
As of nowExenatideOur role ruleTestedCurrent
As of nowExenatideOur role ruleTestedCurrent
As of nowDapagliflozinOur role ruleTestedCurrent
As of nowDapagliflozinOur role ruleTestedCurrent